On PR Newswire: Cision 2019 State of the Media Report, Hudson Media to Acquire National Enquirer, FDA Releases Statement on Measles Vaccine

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire for Journalists. Here are some of this week’s most newsworthy:

Chart from Cision 2019 State of the Media: The availability of audience metrics like views and engagement has changed the way journalists evaluate stories.

Source: PRNewsfoto/Cision

Cision 2019 State of the Media Report Reveals a Decline in Distrust of the Media and Growing Concerns About Staffing and Resources

To uncover the latest trends and biggest challenges facing the media industry, Cision released on April 23 its 2019 State of the Media Report, the company’s 10th annual State of the Media. This year’s report was Cision’s largest ever, surveying nearly 2,000 journalists from 10 countries around the world, to learn about the main issues facing the global media industry in 2019, and how PR and communications professionals can better work with their journalist counterparts.

National Enquirer logo

Source: PRNewsfoto/National Enquirer

American Media, LLC Reaches Agreement to Sell Tabloids, Including National Enquirer, to Hudson Media

American Media, LLC announced on April 18 that it has reached an agreement in principle with James Cohen, the owner and CEO of Hudson Media, for the sale of its newsprint tabloids, including the National Enquirer (U.S. and U.K. editions), Globe, and National Examiner. The agreement also includes a multi-year service contract that will generate substantial fees for American Media to provide publishing, financial, and distribution services for the tabloid brands.

Silhouette of an oil pump

Source: PRNewsfoto/Oil pump

Anadarko Confirms Receipt of Unsolicited Proposal from Occidental

Anadarko Petroleum Corp. confirmed that it has received an unsolicited proposal from Occidental Petroleum Corp. on April 24 under which Anadarko shareholders would receive $38 in cash and 0.6094 shares of Occidental common stock for each share of Anadarko common stock.

FDA sign in front of a building

Source: PRNewsfoto/FDA

Statement from Peter Marks, M.D., Ph.D., Director of FDA’s Center for Biologics Evaluation & Research, on FDA’s Continued Confidence in Safety and Effectiveness of Measles, Mumps, and Rubella Vaccine

The Food & Drug Administration (FDA) issued the following on April 22: The FDA is a public health agency that always strives to use the best available scientific evidence to promote and protect the well-being of individuals. It deeply concerns us when we see preventable diseases such as measles or mumps reemerging in the U.S. and threatening our communities. The World Health Organization recently named vaccine hesitancy one of the top 10 threats to global health. In this time of multiple measles outbreaks, and as we approach National Infant Immunization Week, we want to underscore our continued confidence in the safety and effectiveness of the vaccines that are highly successful at preventing – in some cases, nearly eradicating – preventable diseases.

United Airlines debuts blue aircraft livery

Source: PRNewsfoto/United Airlines

Out with the Gold, in with the Blue — United Airlines Unveils its Next Fleet Paint Design

On April 24, United Airlines introduced customers and employees to a modernized aircraft livery, which will bring a refreshed look to its fleet. The design is a visual representation of United’s ongoing brand evolution while staying true to the history it has developed over the past 93 years of proudly serving customers around the world.

Want to see more news like this? Keep up with the latest news in your coverage area with a customized newsfeed. Click here to sign up now or email us to fine-tune your existing profile.

Larry Grady is online content manager at PR Newswire for Journalists. He has worked in business media for nearly 30 years and enjoys reality TV and daydreaming about travel and wine.

Leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s